Skip to main content
Caplight Logo









Filtricine

Filtricine

Private
Santa Clara, CaliforniaHealthcare & Life Scienceshttps://filtricine.com/

Last Round

Seed

Aug 3, 2021

Total Funding Raised

$250,000

Momentum

Top 50%

of companies Caplight tracks

Company Overview

Filtricine is a clinical-stage biotechnology company that develops medical food products designed to treat cancer through Targeted Nutrients Deprivation (TND).

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Clinical Trials, Precision Medicine

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

medical foodfood as medicinetargeted nutrient deprivationTNDcancer therapymetabolic cancer therapynutritional oncologydrug-free cancer treatmentclinical nutritionmodified dialysiscancer dietbiotechnologyprecision medicine

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Filtricine Comparables

Compare Filtricine with similar companies based on industry and business-model similarity.

Filtricine comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Faeth Therapeutics, Inc.
77%
Nestlé
67%
Abbott Laboratories
63%

Filtricine Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedAug 3, 2021
AcceleratorSep 20, 2018

Key People

Founding team and executive leadership

Grace Xiaolu Yang

Chief Operating Officer And Vice President Of Research, Co-Founder

Founding Team

Filtricine Investors

Notable investors and investment history

Filtricine investors
InvestorRounds
Berkeley Catalyst FundSeed
Boutique Venture PartnersSeed
IndieBioAccelerator
Bluestein VenturesSeed
Sand Hill AngelsSeed
SOSVAccelerator, Seed
True VenturesSeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jun 18, 2026

    Monthly visitors increased 32% MoM.

  • May 18, 2026

    Monthly visitors increased 31% MoM to 1.6K.

Filtricine Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Filtricine Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Filtricine's valuation, stock price, and market status.

Firmographic Details

HeadquartersSanta Clara, California
Employee Range5
Year Founded2017
Last FundingAug 3, 2021

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?